Ofloxacine Viatris

Ofloxacin, the active ingredient in Ofloxacine Viatris, is a fluoroquinolone antibiotic presented as a 0.3% ophthalmic solution for topical eye use. It treats bacterial conjunctivitis and other eye infections in adults and children. GNH USA supplies Ofloxacine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ofloxacine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacine Viatris is a fluoroquinolone that targets bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and speeds the healing process. - Corneal ulcer: helps eradicate the infecting organisms, facilitating corneal repair. - Post‑surgical eye prophylaxis: prevents bacterial contamination after ocular procedures. - External ocular inflammation: diminishes infection‑related inflammation in the conjunctiva and cornea.

Ofloxacine Viatris may elicit a range of ocular and systemic reactions.

Common Side Effects: - Eye irritation - Burning sensation - Redness - Tearing - Temporary blurred vision - Mild headache

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome - Toxic epidermal necrolysis - Corneal ulcer worsening - Vision loss - Persistent ocular pain

When using Ofloxacine Viatris, consider the following safety measures:

- Assess the type of infection: confirm that the infection is susceptible to fluoroquinolones. - Monitor for allergic reactions : watch for signs of rash or hives . - Avoid use in patients with known tetr  t t t t  g t  g t. - Use the recommended dosage : follow the prescribed instructions - Store at below 25°C: keep the original pack and protect from moist  g - -  

The